United StatesChlorthalidone Tablets, USP 25 mg, 100 tablets per bottle (NDC 64980-599-01), batch RISA24002, exp. 04/2027, manufactured by Inventia Healthcare Limited, are being recalled in the U.S. nationwide. The recall is due to failed dissolution specifications and is ongoing.
What's being recalled
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Recalling firm: Inventia Healthcare Limited, Kalyan, N/A, India.
How to identify it
Batch # RISA24002; Exp Date: 04/2027
The hazard
Failed Dissolution Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)